{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:29:36Z","timestamp":1783571376201,"version":"3.55.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundaci\u00f3 per a la Recerca en Oncologia i Immunologia"},{"DOI":"10.13039\/100008050","name":"Cellex Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Agencia Estatal de Investigaci\u00f3n,Spain","award":["Juan de la Cierva"],"award-info":[{"award-number":["Juan de la Cierva"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola contra el c\u00e1ncer","award":["Postdoctoral grant"],"award-info":[{"award-number":["Postdoctoral grant"]}]},{"name":"La Marat\u00f3 TV3","award":["201915-30-31"],"award-info":[{"award-number":["201915-30-31"]}]},{"name":"Spanish Ministry of Education","award":["FPU"],"award-info":[{"award-number":["FPU"]}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"crossref","award":["PREDOCS-UB fellowship"],"award-info":[{"award-number":["PREDOCS-UB fellowship"]}],"id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Ministry of Economy and Competitiveness","award":["PID2019-104991RB-I00"],"award-info":[{"award-number":["PID2019-104991RB-I00"]}]},{"name":"Becas Leonardo 2018","award":["BBM-TRA-0041"],"award-info":[{"award-number":["BBM-TRA-0041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A better understanding of ductal carcinoma in situ (DCIS) is urgently needed to identify these preinvasive lesions as distinct clinical entities. Semaphorin 3F (SEMA3F) is a soluble axonal guidance molecule, and its coreceptors Neuropilin 1 (NRP1) and NRP2 are strongly expressed in invasive epithelial BC cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized two cell line models to represent the progression from a healthy state to the mild-aggressive or ductal carcinoma in situ (DCIS) stage and, ultimately, to invasive cell lines. Additionally, we employed in vivo models and conducted analyses on patient databases to ensure the translational relevance of our results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We revealed SEMA3F as a promoter of invasion during the DCIS-to-invasive ductal carcinoma transition in breast cancer (BC) through the action of NRP1 and NRP2. In epithelial cells, SEMA3F activates epithelialmesenchymal transition, whereas it promotes extracellular matrix degradation and basal membrane and myoepithelial cell layer breakdown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together with our patient database data, these proof-of-concept results reveal new SEMA3F-mediated mechanisms occurring in the most common preinvasive BC lesion, DCIS, and represent potent and direct activation of its transition to invasion. Moreover, and of clinical and therapeutic relevance, the effects of SEMA3F can be blocked directly through its coreceptors, thus preventing invasion and keeping DCIS lesions in the preinvasive state.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-024-01871-0","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T07:02:27Z","timestamp":1723532547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The SEMA3F-NRP1\/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"N\u00faria","family":"Moragas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fernandez-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Recalde-Percaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Inman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"L\u00f3pez-Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Bergholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Noguera-Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"del Burgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xieng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Sorlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Bragado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Carb\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"1871_CR1","volume-title":"Cancer facts & figures 2020","author":"Society AC","year":"2020","unstructured":"Society AC. Cancer facts & figures 2020. Atlanta: American Cancer Society; 2020."},{"key":"1871_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen EJ, Elshof LE, Visser LL, Rutgers EJT, Winter-Warnars HAO, Lips EH, Wesseling J. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast. 2017;31:274\u201383.","journal-title":"Breast"},{"key":"1871_CR3","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-19-2563","volume":"26","author":"F Pareja","year":"2020","unstructured":"Pareja F, Brown DN, Lee JY, Da Cruz Paula A, Selenica P, Bi R, Geyer FC, Gazzo A, da Silva EM, Vahdatinia M, et al. Whole-exome sequencing analysis of the progression from non-low grade ductal carcinoma in situ to invasive ductal carcinoma. Clin Cancer Res. 2020;26:3682.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"1871_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","volume":"121","author":"M van Seijen","year":"2019","unstructured":"van Seijen M, Lips EH, Thompson AM, Nik-Zainal S, Futreal A, Hwang ES, Verschuur E, Lane J, Jonkers J, Rea DW, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285\u201392.","journal-title":"Br J Cancer"},{"issue":"4","key":"1871_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10911-018-9409-z","volume":"23","author":"AC Nelson","year":"2018","unstructured":"Nelson AC, Machado HL, Schwertfeger KL. Breaking through to the other side: microenvironment contributions to DCIS initiation and progression. J Mammary Gland Biol Neoplasia. 2018;23(4):207\u201321.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"5","key":"1871_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"2","key":"1871_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-009-0654-0","volume":"123","author":"M Sharma","year":"2010","unstructured":"Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat. 2010;123(2):397\u2013404.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1871_CR8","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/bcr2222","volume":"11","author":"XJ Ma","year":"2009","unstructured":"Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11(1):R7.","journal-title":"Breast Cancer Res"},{"issue":"Pt 1","key":"1871_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/jcs.115.1.39","volume":"115","author":"T Gudjonsson","year":"2002","unstructured":"Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 2002;115(Pt 1):39\u201350.","journal-title":"J Cell Sci"},{"issue":"6142","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ, Frenette PS. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341(6142):1236361.","journal-title":"Science"},{"issue":"250","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"250115","DOI":"10.1126\/scitranslmed.3009569","volume":"6","author":"CM Zhao","year":"2014","unstructured":"Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, et al. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6(250):250115.","journal-title":"Sci Transl Med"},{"issue":"2","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s10555-023-10095-1","volume":"42","author":"Q Cui","year":"2023","unstructured":"Cui Q, Jiang D, Zhang Y, Chen C. The tumor-nerve circuit in breast cancer. Cancer Metastasis Rev. 2023;42(2):543\u201374.","journal-title":"Cancer Metastasis Rev"},{"key":"1871_CR13","first-page":"39","volume":"9","author":"M Gruet","year":"2020","unstructured":"Gruet M, Cotton D, Coveney C, Boocock DJ, Wagner S, Komorowski L, Rees RC, Pockley AG, Garner AC, Wallis JD, et al. \u03b22-adrenergic signalling promotes cell migration by upregulating expression of the metastasis-associated molecule LYPD3. Biology (Basel). 2020;9:39.","journal-title":"Biology (Basel)"},{"issue":"36","key":"1871_CR14","doi-asserted-by":"publisher","first-page":"39307","DOI":"10.18632\/oncotarget.5624","volume":"6","author":"B Leyh","year":"2015","unstructured":"Leyh B, Dittmer A, Lange T, Martens JW, Dittmer J. Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)\/B-cell leukemia\/lymphoma 3 (Bcl-3) axis. Oncotarget. 2015;6(36):39307\u201328.","journal-title":"Oncotarget"},{"issue":"3","key":"1871_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.02.005","volume":"31","author":"B Boilly","year":"2017","unstructured":"Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve dependence: From regeneration to cancer. Cancer Cell. 2017;31(3):342\u201354.","journal-title":"Cancer Cell"},{"issue":"5","key":"1871_CR16","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.18632\/oncotarget.6543","volume":"7","author":"P Fernandez-Nogueira","year":"2016","unstructured":"Fernandez-Nogueira P, Bragado P, Almendro V, Ametller E, Rios J, Choudhury S, Mancino M, Gascon P. Differential expression of neurogenes among breast cancer subtypes identifies high risk patients. Oncotarget. 2016;7(5):5313\u201326.","journal-title":"Oncotarget"},{"issue":"1","key":"1871_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13058-018-0977-z","volume":"20","author":"A Zubeldia-Plazaola","year":"2018","unstructured":"Zubeldia-Plazaola A, Recalde-Percaz L, Moragas N, Alcaraz M, Chen X, Mancino M, Fernandez-Nogueira P, de Prats PM, Guzman F, Noguera-Castells A, et al. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis. Breast Cancer Res. 2018;20(1):65.","journal-title":"Breast Cancer Res"},{"issue":"14","key":"1871_CR18","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1242\/dev.051318","volume":"138","author":"HL Goel","year":"2011","unstructured":"Goel HL, Bae D, Pursell B, Gouvin LM, Lu S, Mercurio AM. Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development. 2011;138(14):2969\u201376.","journal-title":"Development"},{"issue":"2","key":"1871_CR19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0092-8674(93)80064-L","volume":"75","author":"Y Luo","year":"1993","unstructured":"Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell. 1993;75(2):217\u201327.","journal-title":"Cell"},{"issue":"18","key":"1871_CR20","doi-asserted-by":"publisher","first-page":"8708","DOI":"10.1158\/0008-5472.CAN-06-3612","volume":"67","author":"VA Potiron","year":"2007","unstructured":"Potiron VA, Sharma G, Nasarre P, Clarhaut JA, Augustin HG, Gemmill RM, Roche J, Drabkin HA. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res. 2007;67(18):8708\u201315.","journal-title":"Cancer Res"},{"key":"1871_CR21","doi-asserted-by":"publisher","first-page":"11789","DOI":"10.1038\/srep11789","volume":"5","author":"H Nakayama","year":"2015","unstructured":"Nakayama H, Bruneau S, Kochupurakkal N, Coma S, Briscoe DM, Klagsbrun M. Regulation of mTOR signaling by semaphorin 3F-neuropilin 2 interactions in vitro and in vivo. Sci Rep. 2015;5:11789.","journal-title":"Sci Rep"},{"issue":"8","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1172\/JCI44110","volume":"120","author":"M Klagsbrun","year":"2010","unstructured":"Klagsbrun M, Shimizu A. Semaphorin 3E, an exception to the rule. J Clin Invest. 2010;120(8):2658\u201360.","journal-title":"J Clin Invest"},{"issue":"6","key":"1871_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0896-6273(00)80648-0","volume":"21","author":"H Chen","year":"1998","unstructured":"Chen H, He Z, Bagri A, Tessier-Lavigne M. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron. 1998;21(6):1283\u201390.","journal-title":"Neuron"},{"issue":"1","key":"1871_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/cr.2011.198","volume":"22","author":"A Sakurai","year":"2012","unstructured":"Sakurai A, Do\u00e7i CL, Gutkind JS. Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer. Cell Res. 2012;22(1):23\u201332.","journal-title":"Cell Res"},{"key":"1871_CR25","doi-asserted-by":"publisher","first-page":"e41162","DOI":"10.7554\/eLife.41162","volume":"8","author":"H Sar Shalom","year":"2019","unstructured":"Sar Shalom H, Goldner R, Golan-Vaishenker Y, Yaron A. Balance between BDNF and Semaphorins gates the innervation of the mammary gland. Elife. 2019;8:e41162.","journal-title":"Elife"},{"issue":"9","key":"1871_CR26","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1172\/JCI21378","volume":"114","author":"DR Bielenberg","year":"2004","unstructured":"Bielenberg DR, Hida Y, Shimizu A, Kaipainen A, Kreuter M, Kim CC, Klagsbrun M. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest. 2004;114(9):1260\u201371.","journal-title":"J Clin Invest"},{"issue":"3","key":"1871_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10911-011-9225-1","volume":"16","author":"GC Harburg","year":"2011","unstructured":"Harburg GC, Hinck L. Navigating breast cancer: axon guidance molecules as breast cancer tumor suppressors and oncogenes. J Mammary Gland Biol Neoplasia. 2011;16(3):257\u201370.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"1871_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2559.2011.03922.x","volume":"59","author":"CA Staton","year":"2011","unstructured":"Staton CA, Shaw LA, Valluru M, Hoh L, Koay I, Cross SS, Reed MW, Brown NJ. Expression of class 3 semaphorins and their receptors in human breast neoplasia. Histopathology. 2011;59(2):274\u201382.","journal-title":"Histopathology"},{"key":"1871_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-9966-27-38","volume":"27","author":"M Campioni","year":"2008","unstructured":"Campioni M, Ambrogi V, Pompeo E, Citro G, Castelli M, Spugnini EP, Gatti A, Cardelli P, Lorenzon L, Baldi A, et al. Identification of genes down-regulated during lung cancer progression: a cDNA array study. J Exp Clin Cancer Res. 2008;27:38.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1871_CR30","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1089\/dna.2019.4904","volume":"39","author":"K Ye","year":"2020","unstructured":"Ye K, Ouyang X, Wang Z, Yao L, Zhang G. SEMA3F promotes liver hepatocellular carcinoma metastasis by activating focal adhesion pathway. DNA Cell Biol. 2020;39(3):474\u201383.","journal-title":"DNA Cell Biol"},{"key":"1871_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.omtn.2021.03.014","volume":"24","author":"W Lou","year":"2021","unstructured":"Lou W, Wang W, Chen J, Wang S, Huang Y. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma. Mol Ther Nucleic Acids. 2021;24:845\u201355.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"Suppl 5","key":"1871_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12920-020-0682-5","volume":"13","author":"X Zhang","year":"2020","unstructured":"Zhang X, Klamer B, Li J, Fernandez S, Li L. A pan-cancer study of class-3 semaphorins as therapeutic targets in cancer. BMC Med Genomics. 2020;13(Suppl 5):45.","journal-title":"BMC Med Genomics"},{"issue":"5","key":"1871_CR33","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/0008-5472.CAN-07-2225","volume":"68","author":"A Rizki","year":"2008","unstructured":"Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, et al. A human breast cell model of preinvasive to invasive transition. Cancer Res. 2008;68(5):1378\u201387.","journal-title":"Cancer Res"},{"issue":"7","key":"1871_CR34","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1128\/MCB.22.7.2111-2123.2002","volume":"22","author":"WC Hahn","year":"2002","unstructured":"Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol. 2002;22(7):2111\u201323.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1871_CR35","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","volume":"18","author":"JP Morgenstern","year":"1990","unstructured":"Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 1990;18(12):3587\u201396.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1871_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.molonc.2007.02.004","volume":"1","author":"PA Kenny","year":"2007","unstructured":"Kenny PA, Lee GY, Myers CA, Neve RM, Semeiks JR, Spellman PT, Lorenz K, Lee EH, Barcellos-Hoff MH, Petersen OW, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007;1(1):84\u201396.","journal-title":"Mol Oncol"},{"issue":"3","key":"1871_CR37","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10549-011-1894-3","volume":"133","author":"ES Knudsen","year":"2012","unstructured":"Knudsen ES, Ertel A, Davicioni E, Kline J, Schwartz GF, Witkiewicz AK. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res Treat. 2012;133(3):1009\u201324.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1871_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1172\/JCI63146","volume":"124","author":"Y Onodera","year":"2014","unstructured":"Onodera Y, Nam JM, Bissell MJ. Increased sugar uptake promotes oncogenesis via EPAC\/RAP1 and O-GlcNAc pathways. J Clin Invest. 2014;124(1):367\u201384.","journal-title":"J Clin Invest"},{"issue":"4","key":"1871_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth1015","volume":"4","author":"GY Lee","year":"2007","unstructured":"Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007;4(4):359\u201365.","journal-title":"Nat Methods"},{"key":"1871_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcell.2015.00032","volume":"3","author":"A Zubeldia-Plazaola","year":"2015","unstructured":"Zubeldia-Plazaola A, Ametller E, Mancino M, de Prats PM, Lopez-Plana A, Guzman F, Vinyals L, Pastor-Arroyo EM, Almendro V, Fuster G, et al. Comparison of methods for the isolation of human breast epithelial and myoepithelial cells. Front Cell Dev Biol. 2015;3:32.","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"1871_CR41","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-12-4573","volume":"73","author":"S Garcia-Recio","year":"2013","unstructured":"Garcia-Recio S, Fuster G, Fernandez-Nogueira P, Pastor-Arroyo EM, Park SY, Mayordomo C, Ametller E, Mancino M, Gonzalez-Farre X, Russnes HG, et al. Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer. Cancer Res. 2013;73(21):6424\u201334.","journal-title":"Cancer Res"},{"key":"1871_CR42","first-page":"20","volume":"4","author":"C Jedeszko","year":"2008","unstructured":"Jedeszko C, Sameni M, Olive MB, Moin K, Sloane BF. Visualizing protease activity in living cells: from two dimensions to four dimensions. Curr Protoc Cell Biol. 2008;4:20.","journal-title":"Curr Protoc Cell Biol"},{"issue":"6","key":"1871_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1158\/1078-0432.CCR-19-0353","volume":"26","author":"P Fern\u00e1ndez-Nogueira","year":"2020","unstructured":"Fern\u00e1ndez-Nogueira P, Mancino M, Fuster G, L\u00f3pez-Plana A, Jauregui P, Almendro V, Enreig E, Men\u00e9ndez S, Rojo F, Noguera-Castells A, et al. Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation. Clin Cancer Res. 2020;26(6):1432\u201348.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1871_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017911","volume":"6","author":"M Ringner","year":"2011","unstructured":"Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS ONE. 2011;6(3): e17911.","journal-title":"PLoS ONE"},{"issue":"1","key":"1871_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207\u201310.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1871_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.molonc.2010.06.007","volume":"4","author":"AA Muggerud","year":"2010","unstructured":"Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Borresen-Dale AL, Sorlie T, et al. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Mol Oncol. 2010;4(4):357\u201368.","journal-title":"Mol Oncol"},{"issue":"43","key":"1871_CR47","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1871_CR48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41523-020-0167-x","volume":"6","author":"H Bergholtz","year":"2020","unstructured":"Bergholtz H, Lien TG, Swanson DM, Frigessi A. Oslo Breast Cancer Research C, Daidone MG, Tost J, Warnberg F, Sorlie T: contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions. NPJ Breast Cancer. 2020;6:26.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"1871_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13058-017-0812-y","volume":"19","author":"MR Aure","year":"2017","unstructured":"Aure MR, Vitelli V, Jernstrom S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Luders T, et al. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Res. 2017;19(1):44.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"1871_CR50","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr2632","volume":"12","author":"VD Haakensen","year":"2010","unstructured":"Haakensen VD, Biong M, Lingjaerde OC, Holmen MM, Frantzen JO, Chen Y, Navjord D, Romundstad L, Luders T, Bukholm IK, et al. Expression levels of uridine 5\u2032-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Breast Cancer Res. 2010;12(4):R65.","journal-title":"Breast Cancer Res"},{"key":"1871_CR51","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"6","key":"1871_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti D, Tamma R, Annese T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol. 2020;13(6): 100773.","journal-title":"Transl Oncol"},{"key":"1871_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lfs.2016.05.036","volume":"157","author":"A Patel","year":"2016","unstructured":"Patel A, Sabbineni H, Clarke A, Somanath PR. Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis. Life Sci. 2016;157:52\u201361.","journal-title":"Life Sci"},{"issue":"7","key":"1871_CR54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrc1926","volume":"6","author":"B Bierie","year":"2006","unstructured":"Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer. 2006;6(7):506\u201320.","journal-title":"Nat Rev Cancer"},{"key":"1871_CR55","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2741\/4364","volume":"20","author":"ES Radisky","year":"2015","unstructured":"Radisky ES, Radisky DC. Matrix metalloproteinases as breast cancer drivers and therapeutic targets. Front Biosci (Landmark Ed). 2015;20:1144\u201363.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1871_CR56","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1101\/sqb.2005.70.013","volume":"70","author":"MJ Bissell","year":"2005","unstructured":"Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol. 2005;70:343\u201356.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"14","key":"1871_CR57","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000;92(14):1185\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1871_CR58","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ccr.2008.03.007","volume":"13","author":"M Hu","year":"2008","unstructured":"Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13(5):394\u2013406.","journal-title":"Cancer Cell"},{"issue":"11","key":"1871_CR59","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.ajpath.2015.07.004","volume":"185","author":"TD Russell","year":"2015","unstructured":"Russell TD, Jindal S, Agunbiade S, Gao D, Troxell M, Borges VF, Schedin P. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression. Am J Pathol. 2015;185(11):3076\u201389.","journal-title":"Am J Pathol"},{"issue":"2","key":"1871_CR60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massague","year":"2008","unstructured":"Massague J. TGFbeta in cancer. Cell. 2008;134(2):215\u201330.","journal-title":"Cell"},{"issue":"6958","key":"1871_CR61","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577\u201384.","journal-title":"Nature"},{"issue":"50","key":"1871_CR62","doi-asserted-by":"publisher","first-page":"46707","DOI":"10.1074\/jbc.M106176200","volume":"276","author":"NA Bhowmick","year":"2001","unstructured":"Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J Biol Chem. 2001;276(50):46707\u201313.","journal-title":"J Biol Chem"},{"issue":"3","key":"1871_CR63","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3390\/ijms20030490","volume":"20","author":"AM Mercurio","year":"2019","unstructured":"Mercurio AM. VEGF\/neuropilin signaling in cancer stem cells. Int J Mol Sci. 2019;20(3):490.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1871_CR64","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1038\/s41598-017-03280-0","volume":"7","author":"A Naik","year":"2017","unstructured":"Naik A, Al-Zeheimi N, Bakheit CS, Al Riyami M, Al Jarrah A, Al Moundhri MS, Al Habsi Z, Basheer M, Adham SA. Neuropilin-1 associated molecules in the blood distinguish poor prognosis breast cancer: a cross-sectional study. Sci Rep. 2017;7(1):3301.","journal-title":"Sci Rep"},{"key":"1871_CR65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13046-016-0291-5","volume":"35","author":"L Li","year":"2016","unstructured":"Li L, Jiang X, Zhang Q, Dong X, Gao Y, He Y, Qiao H, Xie F, Xie X, Sun X. Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors. J Exp Clin Cancer Res. 2016;35:16.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1871_CR66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1189\/jlb.0208090","volume":"84","author":"Y Glinka","year":"2008","unstructured":"Glinka Y, Prud\u2019homme GJ. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol. 2008;84(1):302\u201310.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"1871_CR67","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/onc.2010.496","volume":"30","author":"S Samuel","year":"2011","unstructured":"Samuel S, Fan F, Dang LH, Xia L, Gaur P, Ellis LM. Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells. Oncogene. 2011;30(10):1205\u201312.","journal-title":"Oncogene"},{"issue":"10","key":"1871_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023208","volume":"6","author":"S Samuel","year":"2011","unstructured":"Samuel S, Gaur P, Fan F, Xia L, Gray MJ, Dallas NA, Bose D, Rodriguez-Aguayo C, Lopez-Berestein G, Plowman G, et al. Neuropilin-2 mediated beta-catenin signaling and survival in human gastro-intestinal cancer cell lines. PLoS ONE. 2011;6(10): e23208.","journal-title":"PLoS ONE"},{"issue":"22","key":"1871_CR69","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1158\/1078-0432.CCR-09-1810","volume":"15","author":"P Gaur","year":"2009","unstructured":"Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, et al. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res. 2009;15(22):6763\u201370.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1871_CR70","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/bcr1286","volume":"7","author":"MC Adriance","year":"2005","unstructured":"Adriance MC, Inman JL, Petersen OW, Bissell MJ. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res. 2005;7(5):190\u20137.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"1871_CR71","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1158\/0008-5472.CAN-11-3732","volume":"72","author":"A Akhavan","year":"2012","unstructured":"Akhavan A, Griffith OL, Soroceanu L, Leonoudakis D, Luciani-Torres MG, Daemen A, Gray JW, Muschler JL. Loss of cell-surface laminin anchoring promotes tumor growth and is associated with poor clinical outcomes. Cancer Res. 2012;72(10):2578\u201388.","journal-title":"Cancer Res"},{"issue":"3","key":"1871_CR72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1044-579X(02)00023-8","volume":"12","author":"M Patarroyo","year":"2002","unstructured":"Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol. 2002;12(3):197\u2013207.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1871_CR73","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ijc.10611","volume":"101","author":"JM Stephenson","year":"2002","unstructured":"Stephenson JM, Banerjee S, Saxena NK, Cherian R, Banerjee SK. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int J Cancer. 2002;101(5):409\u201314.","journal-title":"Int J Cancer"},{"issue":"Pt 11","key":"1871_CR74","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1242\/jcs.030197","volume":"122","author":"L Capparuccia","year":"2009","unstructured":"Capparuccia L, Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment\u2013two sides of a coin. J Cell Sci. 2009;122(Pt 11):1723\u201336.","journal-title":"J Cell Sci"},{"issue":"11","key":"1871_CR75","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461\u201373.","journal-title":"Oncogene"},{"issue":"3","key":"1871_CR76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10549-014-3040-5","volume":"146","author":"M Fan","year":"2014","unstructured":"Fan M, Sethuraman A, Brown M, Sun W, Pfeffer LM. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer. Breast Cancer Res Treat. 2014;146(3):487\u2013502.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1871_CR77","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.7150\/jca.19723","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Fei F, Li S, Zhao Y, Yang Z, Qu J, Zhang X, Yin Y, Zhang S. The role of beta-catenin in the initiation and metastasis of TA2 mice spontaneous breast cancer. J Cancer. 2017;8(11):2114\u201323.","journal-title":"J Cancer"},{"issue":"2","key":"1871_CR78","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10911-010-9177-x","volume":"15","author":"ES Radisky","year":"2010","unstructured":"Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 2010;15(2):201\u201312.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"7","key":"1871_CR79","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1158\/1541-7786.MCR-09-0523","volume":"8","author":"Q Shen","year":"2010","unstructured":"Shen Q, Lee ES, Pitts RL, Wu MH, Yuan SY. Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2-mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res. 2010;8(7):939\u201351.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1871_CR80","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<118::AID-IJC3>3.0.CO;2-8","volume":"89","author":"A Remacle","year":"2000","unstructured":"Remacle A, McCarthy K, Noel A, Maguire T, McDermott E, O\u2019Higgins N, Foidart JM, Duffy MJ. High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer. 2000;89(2):118\u201321.","journal-title":"Int J Cancer"},{"issue":"7","key":"1871_CR81","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David CJ, Massague J. Contextual determinants of TGFbeta action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19(7):419\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1871_CR82","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12935-019-1068-7","volume":"19","author":"L Wang","year":"2019","unstructured":"Wang L, Xu C, Liu X, Yang Y, Cao L, Xiang G, Liu F, Wang S, Liu J, Meng Q, et al. TGF-beta1 stimulates epithelial-mesenchymal transition and cancer-associated myoepithelial cell during the progression from in situ to invasive breast cancer. Cancer Cell Int. 2019;19:343.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"1871_CR83","first-page":"613","volume":"29","author":"J Chod","year":"2008","unstructured":"Chod J, Zavadova E, Halaska MJ, Strnad P, Fucikova T, Rob L. Preoperative transforming growth factor-beta 1 (TGF-beta 1) plasma levels in operable breast cancer patients. Eur J Gynaecol Oncol. 2008;29(6):613\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"6\u20137","key":"1871_CR84","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","volume":"40","author":"G Jenkins","year":"2008","unstructured":"Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol. 2008;40(6\u20137):1068\u201378.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"1871_CR85","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/carcin\/bgq281","volume":"32","author":"Y Glinka","year":"2011","unstructured":"Glinka Y, Stoilova S, Mohammed N, Prud\u2019homme GJ. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis. 2011;32(4):613\u201321.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1871_CR86","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0896-6273(00)80371-2","volume":"19","author":"H Chen","year":"1997","unstructured":"Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron. 1997;19(3):547\u201359.","journal-title":"Neuron"},{"issue":"2","key":"1871_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1593\/neo.04481","volume":"7","author":"P Nasarre","year":"2005","unstructured":"Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, Roche J. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia. 2005;7(2):180\u20139.","journal-title":"Neoplasia"},{"key":"1871_CR88","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fonc.2019.01461","volume":"9","author":"A Schulz","year":"2019","unstructured":"Schulz A, Gorodetska I, Behrendt R, Fuessel S, Erdmann K, Foerster S, Datta K, Mayr T, Dubrovska A, Muders MH. Linking NRP2 with EMT and chemoradioresistance in bladder cancer. Front Oncol. 2019;9:1461.","journal-title":"Front Oncol"},{"issue":"1","key":"1871_CR89","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygeno.2004.02.001","volume":"84","author":"FC Cackowski","year":"2004","unstructured":"Cackowski FC, Xu L, Hu B, Cheng SY. Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics. 2004;84(1):82\u201394.","journal-title":"Genomics"},{"issue":"1","key":"1871_CR90","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1038\/s41467-018-04905-2","volume":"9","author":"S Cristea","year":"2018","unstructured":"Cristea S, Polyak K. Dissecting the mammary gland one cell at a time. Nat Commun. 2018;9(1):2473.","journal-title":"Nat Commun"},{"issue":"2","key":"1871_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.humpath.2006.08.017","volume":"38","author":"CA Livasy","year":"2007","unstructured":"Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC. Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol. 2007;38(2):197\u2013204.","journal-title":"Hum Pathol"},{"issue":"1","key":"1871_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2016.01.010","volume":"373","author":"M Luo","year":"2016","unstructured":"Luo M, Hou L, Li J, Shao S, Huang S, Meng D, Liu L, Feng L, Xia P, Qin T, et al. VEGF\/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-\u03baB and \u03b2-catenin. Cancer Lett. 2016;373(1):1\u201311.","journal-title":"Cancer Lett"},{"issue":"12","key":"1871_CR93","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","volume":"40","author":"SH Strand","year":"2022","unstructured":"Strand SH, Rivero-Guti\u00e9rrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2022;40(12):1521-1536.e1527.","journal-title":"Cancer Cell"},{"issue":"5","key":"1871_CR94","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ccell.2023.04.002","volume":"41","author":"SJ Hutten","year":"2023","unstructured":"Hutten SJ, de Bruijn R, Lutz C, Badoux M, Eijkman T, Chao X, Ciwinska M, Sheinman M, Messal H, Herencia-Ropero A, et al. A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression. Cancer Cell. 2023;41(5):986-1002.e1009.","journal-title":"Cancer Cell"},{"key":"1871_CR95","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076022","volume":"383","author":"RSJM Schmitz","year":"2023","unstructured":"Schmitz RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, Liu YH, Byng D, Lynch T, Menegaz BA, et al. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study. BMJ. 2023;383: e076022.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"1871_CR96","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41379-020-00689-3","volume":"34","author":"A Sokolova","year":"2021","unstructured":"Sokolova A, Lakhani SR. Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol. 2021;34(Suppl 1):8\u201314.","journal-title":"Mod Pathol"},{"issue":"3","key":"1871_CR97","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gy\u00f6rffy","year":"2010","unstructured":"Gy\u00f6rffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-024-01871-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:02:47Z","timestamp":1723572167000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-024-01871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1186\/s13058-024-01871-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4052253\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient samples used were obtained from the biobank of the Hospital Clinic de Barcelona (IDBAPS) under the approval of the institutional ethics committee. In vivo experiments were performed according to the Catalan Government Animal Experimentation Ethics Committee regulations (Comit\u00e8 \u00c8tic d\u2019Experimentaci\u00f3 Animal [CEEA]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}